These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions. Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447 [TBL] [Abstract][Full Text] [Related]
4. Fast and sensitive validation of fusion transcripts in whole-genome sequencing data. Hafstað V; Häkkinen J; Persson H BMC Bioinformatics; 2023 Sep; 24(1):359. PubMed ID: 37741966 [TBL] [Abstract][Full Text] [Related]
5. Re-Evaluate Fusion Genes in Prostate Cancer. Wei T; Lu J; Ma T; Huang H; Kocher JP; Wang L Cancer Inform; 2021; 20():11769351211027592. PubMed ID: 34234399 [TBL] [Abstract][Full Text] [Related]
6. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS. van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763 [TBL] [Abstract][Full Text] [Related]
7. Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers. Dehghannasiri R; Freeman DE; Jordanski M; Hsieh GL; Damljanovic A; Lehnert E; Salzman J Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15524-15533. PubMed ID: 31308241 [TBL] [Abstract][Full Text] [Related]
8. Regulatory networks and 5' partner usage of miRNA host gene fusions in breast cancer. Hafstað V; Søkilde R; Häkkinen J; Larsson M; Vallon-Christersson J; Rovira C; Persson H Int J Cancer; 2022 Jul; 151(1):95-106. PubMed ID: 35182081 [TBL] [Abstract][Full Text] [Related]
9. Cancer fusion transcripts with human non-coding RNAs. Mohammad T; Zolotovskaia MA; Suntsova MV; Buzdin AA Front Oncol; 2024; 14():1415801. PubMed ID: 38919532 [TBL] [Abstract][Full Text] [Related]
10. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification. Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of cancer genes by recurrent intergenic fusions. Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391 [TBL] [Abstract][Full Text] [Related]
12. The landscape of chimeric RNAs in bladder urothelial carcinoma. Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082 [TBL] [Abstract][Full Text] [Related]
13. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing. Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853 [TBL] [Abstract][Full Text] [Related]
14. The landscape of long noncoding RNA-involved and tumor-specific fusions across various cancers. Guo M; Xiao ZD; Dai Z; Zhu L; Lei H; Diao LT; Xiong Y Nucleic Acids Res; 2020 Dec; 48(22):12618-12631. PubMed ID: 33275145 [TBL] [Abstract][Full Text] [Related]
15. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Kalyana-Sundaram S; Shankar S; Deroo S; Iyer MK; Palanisamy N; Chinnaiyan AM; Kumar-Sinha C Neoplasia; 2012 Aug; 14(8):702-8. PubMed ID: 22952423 [TBL] [Abstract][Full Text] [Related]
16. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning. Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033 [TBL] [Abstract][Full Text] [Related]
17. Open-access synthetic spike-in mRNA-seq data for cancer gene fusions. Tembe WD; Pond SJ; Legendre C; Chuang HY; Liang WS; Kim NE; Montel V; Wong S; McDaniel TK; Craig DW; Carpten JD BMC Genomics; 2014 Sep; 15(1):824. PubMed ID: 25266161 [TBL] [Abstract][Full Text] [Related]
18. Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC. Mack PC; Keller-Evans RB; Li G; Lofgren KT; Schrock AB; Trabucco SE; Allen JM; Tolba K; Oxnard GR; Huang RSP Oncologist; 2024 Aug; 29(8):e984-e996. PubMed ID: 38401173 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma. He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105 [TBL] [Abstract][Full Text] [Related]